1 USD
+0.02 (+2.04%)
0.9437 USD
-0.06 (-5.63%)
ChartMill assigns a Buy % Consensus number of 43% to ANGN. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 1.53. This target is 53% above the current price.
- ANGN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ANGN.
- In the previous month the buy percentage consensus was at a similar level.
- ANGN was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-06-30 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2022-06-30 | Stifel | Downgrade | Buy -> Hold |
| 2022-05-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-10 | Oppenheimer | Maintains | Outperform |
| 2021-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-27 | Stifel | Maintains | Buy |
| 2021-03-02 | Oppenheimer | Initiate | Outperform |
| 2021-03-02 | Stifel | Initiate | Buy |
| 2021-03-02 | Cowen & Co. | Initiate | Outperform |
| 2021-03-01 | HC Wainwright & Co. | Initiate | Buy |
ANGION BIOMEDICA CORP / ANGN FAQ
Can you provide the average price target for ANGION BIOMEDICA CORP stock?
6 analysts have analysed ANGN and the average price target is 1.53 USD. This implies a price increase of 53% is expected in the next year compared to the current price of 1.
Can you provide the consensus rating for ANGION BIOMEDICA CORP stock?
The consensus rating for ANGION BIOMEDICA CORP (ANGN) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.